I declare WAR on LOVE
http://www.desteni.co.za
http://www.desteni-money.net
http://www.youtube.com/mattifreeman1
http://www.myspace.com/matterfreeman
Equal Money for All from Birth
Dignified Life Campaign
End the fight for survival with Equal Money for All
The Coalition to End Childhood Lead Poisoning, U.S. Environmental Protection Agency (EPA), and U.S. Department of Housing and Urban Development (HUD) are joining the Ad Council today to unveil a new series of national public service advertisements (PSAs) to raise awareness about childhood lead poisoning. The PSAs are being distributed today to kick off National Lead Poisoning Prevention Week (NLPPW). Additionally, the campaign’s social media presence through Facebook and Twitter will reinforce to parents, caregivers and pregnant women that if their home was built before 1978, they should have their child tested for lead poisoning.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52687-ad-council-lead-poisoning-prevention-week-english-psa
After precipitous declines during the prior two quarters, CEO confidence bounced back at year’s end with the largest quarterly gain since the start of the recovery in 2009. The Vistage CEO Confidence Index was 98.8 in the 4th quarter 2011 survey, up from 83.5 in the 3rd quarter, and reaching the highest level since 105.2 was recorded at the start of 2011. The Q4 2011 Vistage CEO Confidence Index reflects responses from 1,641 U.S. CEOs, surveyed between Dec. 12 and Dec. 22, 2011.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/vistage/51156/
The Corporate Executive Board (CEB) (NYSE: EXBD), a leading research and advisory services company, today announced the publication of Executive Guidance 2011, the company’s year-end analysis of industry trends and corporate best practices designed to inform and support business planning. This year’s Executive Guidance focuses on “Intelligent Growth”—a long-term pattern of above-industry performance in both revenue growth and efficiency—and highlights four key management principles that are critical to achieving it. While most companies aspire to create this balance, currently less than 10 percent of global organizations are considered Intelligent Growth companies.
To view Mulimedia News Release, go to http://multivu.prnewswire.com/mnr/executiveboard/45060/
ConAgra Foods® (NYSE: CAG) and Feeding America®, the nation’s leading domestic hunger-relief organization, will premiere “Child Hunger Ends Here: A Special Report” on select NBC stations across the nation on March 19. The 30-minute special, hosted by Al Roker with Natalie Morales, gives viewers a better understanding about the negative effects of hunger on children and how they can help end child hunger.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/conagra/48986/
At the Allen electronic organ installed at Emmanuel Ecumenical Church in Salford. The church was originally Salford Methodist Community Church but in recent years has joined with the local Anglican church to become Emmanuel. A new church is in the process of construction on a different site and due to open next year. It is proposed that this organ will be reinstalled in the new premises. Im playing "Mango Walk" on this Allen electronic organ which dates back to the late 1970s and make use of the "percussion" effect stop at the very end.
Speakeasy (www.speakeasy.net), one of the nation’s leading broadband and voice services providers and a Best Buy company (NYSE:BBY), today announced the extension of their free phone offer, which has successfully eliminated one of the last barriers to VoIP adoption. In March, Speakeasy began offering free Polycom SoundPoint IP 321 VoIP-enabled phones to new business customers who purchase unlimited or global Hosted Voice calling plans and have a minimum of five lines. The promotion was so successful that Speakeasy has made the decision to extend the promotion through the end of June.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/speakeasy/44400/
Join O2 Rugby Reunion this summer and make the comeback to end all comebacks. It's time to put the old team back together and get back out there. Each event has food, drink, competitions, prizes and England players present. Go to http://bit.ly/O2Rugby_YouTube for details.
According to the United Nations, worldwide nearly 1.3 million lives are lost in traffic accidents each year and this number could rise to nearly 1.9 million in the next 10 years. Furthermore, estimates show that nearly 90 percent of all crashes are caused by driver error, making advanced safety systems an important focus for automakers and governing agencies. Bosch offers active and passive safety technologies, as well as driver assistance functions that can help reduce the number of accidents and save lives.
To view Multimedia News Release, go to http://www.multivu.com/mnr/48705-bosch-helps-drivers-avoid-crashes-reduce-injuries
The Medium Extended Air Defense System (MEADS) successfully completed its first flight test today at White Sands Missile Range, N.M.
The PAC-3 Missile Segment Enhancement (MSE) MEADS Certified Missile Round was employed during the test along with the MEADS lightweight launcher and battle manager.
The test demonstrated an unprecedented over-the-shoulder launch of the MSE missile against a simulated target attacking from behind. It required a unique sideways maneuver, demonstrating a 360-degree capability. The missile executed a planned self-destruct sequence at the end of the mission after successfully engaging the simulated threat.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53248-meads-conducts-successful-first-flight-test-white-sands-missile-range
Nobody likes to sell themselves short in life and end up a data entry clerk. If you say your dream is to be an architect you don\'t want to end up tapping a keyboard while you cry out from the sheer mind-numbing boredom of it all.
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
